Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
26.09. | Pharmaceutical Excellence Awards 2024: West Pharmaceutical Services | ||
26.09. | Boehringer Ingelheim opens $66.8m new cancer research facility | ||
26.09. | Union plans Phase III trial for atopic dermatitis after Phase IIb win | ||
26.09. | How can the UK's Labour government transform health and care? | ||
26.09. | Orion and Aitia partner for AI-driven oncology drug discovery | ||
26.09. | MHLW approves MSD's KEYTRUDA for lung and urothelial cancers | ||
26.09. | AskBio and Belief BioMed partner to advance gene therapies | ||
26.09. | Pfizer to withdraw sickle cell treatment OXBRYTA from market | ||
25.09. | Genespire raises $52m in Series B to trial paediatric gene therapy | ||
25.09. | Managing temperature-sensitive injectable drugs in fill finish operations | ||
25.09. | Why a new prescription tracking feature on the NHS app is important for pharmacists | ||
25.09. | Epigenetic drugs show 375% increase in Series A venture financing in 2024 | ||
25.09. | Biologic API Manufacturing Companies (Protein and Peptide) in Contract Manufacturing for the Pharmaceutical Industry | ||
25.09. | Oral Solid Dose Manufacturing Companies in the Pharmaceutical Industry | ||
25.09. | Biotechnology Equipment Manufacturers, Companies and Suppliers for the Pharmaceutical Industry | ||
25.09. | Bavarian Nordic gains US contract for additional mpox vaccine | ||
25.09. | Generate:Biomedicines and Novartis link on protein therapeutics development | ||
25.09. | Pharmaceutical Cleanrooms and Cleanroom Flooring Suppliers | ||
25.09. | FDA hits Ozempic and Mounjaro counterfeit compounders with warning letters | ||
25.09. | AllazoHealth introduces AI offering to enhance medication initiation | ||
25.09. | MHLW approves Eli Lilly's Kinsula to treat Alzheimer's in Japan | ||
24.09. | Telix acquires RLS Radiopharmacies to expand US manufacturing presence | ||
24.09. | Iterum's oral sulopenem acceptance hinges on antibiotic stewardship efforts | ||
24.09. | Takeda's FRUZAQLA approved in Japan for advanced colorectal cancer | ||
24.09. | EMA CHMP recommends AstraZeneca's Fasenra to treat EGPA |